Aspen Pharmacare Holdings Limited (JSE:APN)
South Africa · Delayed Price · Currency is ZAR · Price in ZAc 16,639
-78 (-0.47%)
Nov 6, 2026, 5:03 PM SAST
Aspen Pharmacare Holdings Financials Overview
Financials in millions ZAR. Fiscal year is July - June.
Millions ZAR. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Revenue Revenue Growth | 34,870 | 34,870 | 35,336 | 44,706 | 40,709 | 38,606 |
Revenue Growth | -18.13% | -1.32% | -20.96% | 9.82% | 5.45% | 2.22% |
Gross Profit Gross Profit Growth | 14,799 | 14,799 | 14,650 | 19,416 | 18,869 | 18,256 |
Operating Income Operating Income Growth | 5,249 | 5,249 | 4,414 | 8,867 | 8,929 | 8,740 |
Net Income Net Income Growth | 2,647 | 2,647 | -1,083 | 4,404 | 5,228 | 6,488 |
Earnings Per Share EPS Growth | 5.96 | 5.96 | -2.44 | 9.91 | 11.77 | 14.32 |
EPS Growth | - | - | - | -15.76% | -17.83% | 36.04% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Commercial Pharmaceuticals - Prescription Commercial Pharmaceuticals - Prescription Growth | 9,069 | 9,069 | 9,658 | 11,380 | 10,286 | - |
Commercial Pharmaceuticals - OTC Commercial Pharmaceuticals - OTC Growth | 7,157 | 7,157 | 7,046 | 9,706 | 9,388 | - |
Commercial Pharmaceuticals - Injectables Commercial Pharmaceuticals - Injectables Growth | 9,179 | 9,179 | 8,048 | 9,484 | 10,796 | - |
Manufacturing Manufacturing Growth | 9,465 | 9,465 | 10,584 | 14,136 | 12,190 | 10,948 |
Total Total Growth | 34,870 | 34,870 | 35,336 | 44,706 | 42,660 | 38,606 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Investments Cash & Investments Growth | 15,998 | 15,998 | 6,409 | 12,337 | 10,912 | 6,183 |
Total Debt Total Debt Growth | 15,569 | 15,569 | 36,120 | 36,455 | 29,282 | 22,247 |
Net Cash (Debt) Net Cash Growth | 429 | 429 | -29,711 | -24,118 | -18,370 | -16,064 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 0.97 | 0.97 | -66.92 | -54.30 | -41.36 | -35.46 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 6,869 | 6,869 | 5,159 | 6,225 | 5,520 | 5,374 |
Capital Expenditures CapEx Growth | -2,152 | -2,152 | -2,576 | -3,117 | -2,230 | -1,963 |
Free Cash Flow Free Cash Flow Growth | 4,717 | 4,717 | 2,583 | 3,108 | 3,290 | 3,411 |
Free Cash Flow Growth | 6.62% | 82.62% | -16.89% | -5.53% | -3.55% | -28.64% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Gross Margin | 42.44% | 42.44% | 41.46% | 43.43% | 46.35% | 47.29% |
Operating Margin | 15.05% | 15.05% | 12.49% | 19.83% | 21.93% | 22.64% |
Pretax Margin | -1.20% | -1.20% | -6.25% | 12.78% | 16.10% | 21.07% |
Profit Margin | 7.59% | 7.59% | -3.06% | 9.85% | 12.84% | 16.81% |
FCF Margin | 13.53% | 13.53% | 7.31% | 6.95% | 8.08% | 8.83% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 9, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Dividend Per Share Dividend Per Share Growth | 2.320 | 2.320 | 2.110 | 3.590 | 3.420 | 3.260 |
Dividend Per Share Growth | 9.95% | 9.95% | -41.23% | 4.97% | 4.91% | 24.43% |
Dividend Yield | 1.39% | 1.47% | 1.76% | 1.54% | 1.86% | 2.34% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 9, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
PE Ratio | 27.92 | 26.32 | - | 23.57 | 15.63 | 9.56 |
Forward PE | 14.15 | 13.71 | 9.58 | 12.68 | 10.44 | 7.34 |
P/FCF Ratio | 15.58 | 14.77 | 20.55 | 33.40 | 24.83 | 18.19 |
PS Ratio | 2.11 | 2.00 | 1.50 | 2.32 | 2.01 | 1.61 |